A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
AbbVie
AbbVie
NanOlogy, LLC
AstraZeneca
Eastern Cooperative Oncology Group
Innovent Biologics (Suzhou) Co. Ltd.
Merck Sharp & Dohme LLC
Seoul National University Hospital
H. Lee Moffitt Cancer Center and Research Institute
Oncology Institute of Southern Switzerland
Takeda
Bristol-Myers Squibb
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Samsung Medical Center
Fox Chase Cancer Center
University of Chicago
European Organisation for Research and Treatment of Cancer - EORTC
Hoosier Cancer Research Network
National Cancer Center, Korea